These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 1950642)

  • 21. [Malignant non-Hodgkin's lymphoma of the bony cavity of the face. Apropos of 17 cases].
    Demard F; Santini J; Ettore F; Camuzard JF; Serra C; Bruneton JN; Vallicioni J
    Rev Laryngol Otol Rhinol (Bord); 1989; 110(2):191-5. PubMed ID: 2781188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical significance of immunophenotype in diffuse non-Hodgkin's lymphoma: with special emphasis on the clinical characteristics of T-cell lymphoma].
    Chubachi A; Miura AB; Takatsu H; Yamaguchi A; Nishimura S; Nakayama Y; Akihama T; Miura S; Saitoh M; Watanuki T
    Gan To Kagaku Ryoho; 1991 Jul; 18(8):1303-9. PubMed ID: 2069401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Non-Hodgkin's lymphoma: clinical symptoms, therapy and prognosis in 37 patients].
    Skunca Z; Gverić-Krecak V; Dominis M; Planinc-Peraica A; Jaksić B
    Acta Med Croatica; 2003; 57(4):261-7. PubMed ID: 14639859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-Hodgkin's lymphoma (NHL) of the testicle. A clinicopathologic study of 19 patients.
    Rojo J; Sales V; Paredes A; Soriano J
    In Vivo; 1991; 5(3):297-9. PubMed ID: 1893083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum immunoglobulins in non-Hodgkin's lymphoma patients.
    Planinc-Peraica A; Kolonić SO; Radić-Kristo D; Dominis M; Jaksić B
    Coll Antropol; 2010 Jun; 34(2):407-11. PubMed ID: 20698110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical and prognosis relevance of the Kiel classification of non-Hodgkin lymphomas].
    Brittinger G; Engelhard M
    Verh Dtsch Ges Pathol; 1992; 76():37-46. PubMed ID: 1283273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic laparotomy in non-Hodgkin's lymphoma.
    Jelliffe AM
    Br J Cancer Suppl; 1975 Mar; 2():248-51. PubMed ID: 1182072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-Hodgkin lymphoma: predicting prognostic grade with MR imaging.
    Rehn SM; Nyman RS; Glimelius BL; Hagberg HE; Sundström JC
    Radiology; 1990 Jul; 176(1):249-53. PubMed ID: 2353098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Organ manifestations of malignant lymphoma. Results of 10 years' sonographic follow-up of 550 patients].
    Weiss A; Weiss H; Grühn K
    Ultraschall Med; 1989 Dec; 10(6):284-9. PubMed ID: 2696087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiogenesis measured by expression of CD34 antigen in lymph nodes of patients with non-Hodgkin's lymphoma.
    Mazur G; Wróbel T; Dziegiel P; Jeleń M; Kuliczkowski K; Zabel M
    Folia Histochem Cytobiol; 2004; 42(4):241-3. PubMed ID: 15704651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Downgraded non-Hodgkin's lymphoma in the neck occurring as a secondary malignancy.
    Ogata Y; Setoguchi M; Tahara T; Takahashi M
    ORL J Otorhinolaryngol Relat Spec; 1998; 60(5):295-300. PubMed ID: 9693308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Signs, Symptoms and Complications of Non-Hodgkin's Lymphoma According to Grade and Stage in South Iran.
    Dehghani M; Haddadi S; Vojdani R
    Asian Pac J Cancer Prev; 2015; 16(8):3551-7. PubMed ID: 25921177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relation between enzymatic activities and the degree of malignancy of human lymphomas.
    Vezzoni P; Giardini R; Raineri M; Pozzi MR; Lucchini R; Vezzoni MA; Clerici L; Besana C; Rugarli C; Rilke F
    Eur J Cancer Clin Oncol; 1985 Aug; 21(8):945-50. PubMed ID: 4043177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Centroblast morphology: a morphometric evaluation by means of computer-aided image analysis].
    Bergmann M; Harms H; Albert R; Droese M; Müller-Hermelink HK
    Verh Dtsch Ges Pathol; 1990; 74():211-5. PubMed ID: 1708586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The relationship of non-Hodgkin's lymphoma with P16 protein expression].
    Zhang S; Li F; Shi Y; Li G; Du B; Liu H; Liu W; Chen L; Rong X; Zhang X; Yang G
    Hua Xi Yi Ke Da Xue Xue Bao; 1996 Sep; 27(3):254-7. PubMed ID: 9389056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparative study of nuclear form factor, area and diameter in non-Hodgkin's lymphomas and reactive lymph nodes.
    Crocker J; Jones EL; Curran RC
    J Clin Pathol; 1983 Mar; 36(3):298-302. PubMed ID: 6338055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Expression of P120ctn in non-Hodgkin's lymphoma and its significance].
    Wu Y; Liu WL; Sun HY; Xu HZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Jun; 14(3):508-11. PubMed ID: 16800931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum beta 2 microglobulin in malignant lymphoproliferative disorders.
    Constantinides IP; Pathouli C; Karvountzis G; Papadopoulos P; Varvoutsi-Constantinides M; Eliakis P; Hadziyannis S; Komninos Z
    Cancer; 1985 May; 55(10):2384-9. PubMed ID: 3886124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of flow cytometry studies in B-cell non-Hodgkin lymphoma.
    Rehn S; Glimelius B; Strang P; Sundström C; Tribukait B
    Hematol Oncol; 1990; 8(1):1-12. PubMed ID: 2298418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood clonal B cell excess (CBE) at diagnosis in patients with non-Hodgkin lymphoma (NHL). Relation to clinical stage, histopathology and response to treatment.
    Lindemalm C; Mellstedt H; Nilsson B; Biberfeld P; Björkholm M; Christensson B; Holm G; Johansson B
    Eur J Cancer Clin Oncol; 1987 Jun; 23(6):749-53. PubMed ID: 3115783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.